Early research (Phase 1)Ended earlyNCT03891420
What this trial is testing
Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19
Who this might be right for
COVID-19Yellow Fever
BioCryst Pharmaceuticals 24